Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
about
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationNew Therapeutic Concept of NAD Redox Balance for Cisplatin NephrotoxicityRedox implications in adipose tissue (dys)function--A new look at old acquaintancesSirtuin 1 and sirtuin 3: physiological modulators of metabolismThe role of mammalian sirtuins in the regulation of metabolism, aging, and longevityCisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment StrategiesRedox regulation of mitochondrial functionβ-Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic miceNQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levelsAugmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.Sirtuin activation: a role for plasma membrane in the cell growth puzzleMetabolic reprogramming, caloric restriction and aging.Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid systemThe Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye.SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial functionRole of NADH: quinone oxidoreductase-1 in the tight junctions of colonic epithelial cells.Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice.Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.Tauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular Ca2+ anomalies.Pharmacological activation of Sirt1 ameliorates polyglutamine-induced toxicity through the regulation of autophagy.Metabolites related to gut bacterial metabolism, peroxisome proliferator-activated receptor-alpha activation, and insulin sensitivity are associated with physical function in functionally-limited older adultsAntiobesogenic role of endothelial nitric oxide synthase.Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsAssociation of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome Componentsβ-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microgliaA Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and Emesisβ-Lapachone, a substrate of NAD(P)H:quinone oxidoreductase, induces anti-inflammatory heme oxygenase-1 via AMP-activated protein kinase activation in RAW264.7 macrophages.Thymoquinone, a bioactive component of Nigella sativa, normalizes insulin secretion from pancreatic β-cells under glucose overload via regulation of malonyl-CoAInhibitory effects of a β-dunnione compound MB12662 on gastric secretion and ulcers.Increased Cellular NAD+ Level through NQO1 Enzymatic Action Has Protective Effects on Bleomycin-Induced Lung Fibrosis in Mice.Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.NAD(+) Metabolism in Age-Related Hearing LossFoxo1 integrates insulin signaling with mitochondrial function in the liver.NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.Inactivation of β-Lapachone Cytotoxicity by Filamentous Fungi that Mimic the Human Blood Metabolism.TEMPOL increases NAD(+) and improves redox imbalance in obese mice.NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats.The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1.Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch.Novel RNA-binding activity of NQO1 promotes SERPINA1 mRNA translation.
P2860
Q24293305-78A6D577-AD06-4882-A141-F79E10D336EEQ26765483-3AE96B5F-AEBE-44C2-BBEF-17E4E15DDD0FQ26801347-2CC961B6-A3CE-472D-8339-9A5D4F3AC653Q26828607-AE3CC288-AC85-4810-9A05-C3C32F66A98EQ26865526-F72D0378-CF84-4117-97FB-562185292F1AQ28080842-5DBFAF06-5E80-4B67-B826-4F3F36DCD72BQ28383361-EF3E4BB8-1B1C-4372-908F-A05714FC3F81Q28540678-20BA2838-BA41-437E-A314-80795A14DAFEQ28741474-0CF94EBB-419D-41CC-BB37-C3E82225BCF5Q30669518-DF460E6C-4F35-4800-A3F6-B0A6FCF89CB1Q33354469-B796EE46-687C-498F-A573-33EE0310D697Q33699345-CC97675F-AC5A-41EF-80AE-135CCC177524Q34100489-13248CA5-1F01-4509-9CB6-8A13B15C5997Q34125724-D312B394-143F-4EC1-B545-BF05180D661AQ34272924-F631C663-00C7-4EF7-8632-AB09F64226F6Q34389757-9732A79C-FE28-40D7-8CC7-81EBB77A770EQ34447919-53DE6996-1707-4B19-8724-C25DE4CE5FE5Q34514818-DCA486D5-E13E-4B0F-A0F6-7180050AEC2EQ34718307-81F2B344-A1DD-47A0-B96F-325C3093B523Q34769525-351FD6C7-F202-4904-AED0-11AFFEAB6EDDQ35093075-AC622042-5D0F-4084-8A46-092FD19BA54BQ35540257-DB1EFB9C-FF6E-4E8B-A992-3A24F5C2CB78Q35559692-EE66FBAA-10FC-4D15-A97C-F6D8597FE2BCQ35560789-870627B3-B81B-45D0-A8D5-F2EF068DCC74Q35852416-8F5BD0F0-8651-460A-88F8-2B15585860BDQ36015715-3B17D803-241A-48A0-B36B-0EAE3E00328EQ36670798-165D4835-DEBD-4F3B-9528-B9C4047045CCQ36698724-0A8D6368-07DF-4F81-BB3E-261ECFD34244Q37217349-C11899C3-EE51-4E7A-91F5-5781C0E35AD4Q37362342-E695C380-C454-4122-B538-CAE737C40BE7Q37621369-5E192E91-F914-4A72-A176-4FB36AD9A0FBQ37665360-2DEB04C5-F2D0-4D9A-988F-653C84E2257AQ37715192-09D64E2A-8D0F-4557-8D0A-776D141EA6A5Q37912039-6EBE074E-0DCC-46C9-AB2E-108CCCA828C6Q38779727-2A222B8C-48DD-4788-A4D1-AB3E9E6A0FDFQ38831342-66CD4FC4-2D27-433A-A603-9A47CFC48B5BQ38982506-6E39EA73-F44E-416E-A8EF-1EB5BA65A77DQ39155657-FA005921-EE67-484B-A730-CC30BB910954Q41539407-30876557-76C1-4183-B2A4-0B8EBB33FC8AQ41642043-0A6F0153-1CF4-4CCE-B889-353EFF992CC4
P2860
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological stimulation of ...... nd related phenotypes in mice.
@en
Pharmacological stimulation of ...... nd related phenotypes in mice.
@nl
type
label
Pharmacological stimulation of ...... nd related phenotypes in mice.
@en
Pharmacological stimulation of ...... nd related phenotypes in mice.
@nl
prefLabel
Pharmacological stimulation of ...... nd related phenotypes in mice.
@en
Pharmacological stimulation of ...... nd related phenotypes in mice.
@nl
P2093
P2860
P356
P1433
P1476
Pharmacological stimulation of ...... and related phenotypes in mice
@en
P2093
Cholsoon Jang
Dong Wook Kim
Eun Jin Jo
Gi Ryang Kweon
Hueng-Sik Choi
Ji Hoon Park
Jin Man Kim
Jongkyeong Chung
P2860
P304
P356
10.2337/DB08-1183
P407
P50
P577
2009-01-09T00:00:00Z